Questcor Pharmaceuticals Inc. and Nastech Pharmaceutical Co. Inc. filed a new drug application requesting approval of Nascobal Nasal Spray for the treatment of vitamin B-12 deficiency. (BioWorld Today)

Nastech, Questcor File NDA For Spray Form Of Nascobal

Dec. 31, 2003

By Kim Coghill

Pharmion Files NDA On Vidaza For Myelodysplastic Syndromes

Dec. 30, 2003

By Kim Coghill

Pharmion Corp. filed a new drug application seeking approval to market Vidaza, an orphan-designated product, as a treatment for myelodysplastic syndromes. (BioWorld Today)

Pharmion Files NDA On Vidaza For Myelodysplastic Syndromes

Dec. 30, 2003

By Kim Coghill

Pharmion Corp. filed a new drug application seeking approval to market Vidaza, an orphan-designated product, as a treatment for myelodysplastic syndromes. (BioWorld Today)

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...